SNM applauds House action to build medical isotopes reactor in the US

November 06, 2009

Reston, Va.--SNM applauds the U.S. House of Representatives for its passage of H.R. 3276--the American Medical Isotopes Production Act of 2009.

"The worldwide isotope shortage has long been adversely affecting patients in the U.S.," said Michael M. Graham, Ph.D., M.D., president of SNM. "This important legislation will bring us one step closer to solving this chronic problem."

The American Medical Isotopes Production Act of 2009 was introduced by Congressman Edward J. Markey (D-MA) in July.

"Congressman Markey has worked closely with the medical community, members of industry and other stakeholders to ensure that this important legislation comes to fruition," said Robert W. Atcher, Ph.D., M.B.A., chair of SNM's Domestic Isotope Availability Taskforce. "The time is now to make sure that the U.S. has long-term access to medical isotopes--without having to rely on foreign producers."

Molybdenum-99 (Mo-99) is a critical medical isotope. Technetium-99m--the decay product of Mo-99--is used in more than 16 million diagnostic medical tests annually in the U.S. for the early detection and effective management of cancer, heart disease, thyroid disease and other serious conditions.

There are currently only six foreign producers of Mo-99 approved by the U.S. Food and Drug Administration to import the product into the U.S.--and no domestic facilities exist which are dedicated to the production of Mo-99 for medical uses. These aging foreign reactors regularly experience significant ongoing maintenance issues--frequently causing these reactors to go off-line. These continuing problems were exacerbated with reactors shutting down in Canada and the Netherlands earlier this year. Subsequently, the Canadian government announced that it will no longer produce medical isotopes as of 2016.

"To date, it has not been a pretty picture--and that is why SNM is so supportive of the House's approval of this bill," added Graham.

Most reactors in the world that produce Mo-99 utilize highly enriched uranium (HEU), which can also be used in the construction of nuclear weapons. Under this legislation, nuclear reactors that produce Mo-99 would have to stop using HEU and make the transition to low enriched uranium (LEU) as a replacement.

The American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval. If enacted, this legislation would create a stable and reliable supply of medical isotopes in the U.S.

"This is landmark legislation for patients and all Americans," said Graham.
-end-
About SNM--Advancing Molecular Imaging and Therapy

SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.

Society of Nuclear Medicine

Related Approval Articles from Brightsurf:

COVID-19 shapes political approval ratings
During the early days of the pandemic, COVID-19 created a rally effect around political leaders, according to a large-scale study published Sept.

Improving FDA's COVID-19 vaccine authorization and approval process
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19, and on June 15, the agency revoked this authorization.

Clinical practice guideline approval process introduces potential conflicts of interest
A new study of the approval processes used by the 43 medical-specialty-society members of the Council of Medical Specialty Societies in the US to create evidence-based guidelines finds that most use an approval procedure that has the potential to undermine editorial independence of the guideline development committee.

Examining changes to FDA approval, regulation of pharmaceuticals over 4 decades
Publicly available and Food and Drug Administration (FDA) data were used in this observational study to describe the number and types of prescription drugs approved from 1983 to 2018 and how the approval process and regulation of drugs changed during this period.

One-third of pre-approved prescription drugs have not completed the FDA approval process
The Food and Drug Administration's (FDA) Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.

Lower approval rates evidence of discrimination for same-sex borrowers
Mortgage lenders are less likely to approve loans for same-sex couples.

Leopoldina-Experts call for stricter approval procedures for plant protection products
A number of chemical plant protection products, also known as pesticides, show harmful effects on ecosystems and biodiversity in their current use.

New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.

Less than half of patients prescribed new cholesterol drug receive insurance approval
In the largest study of its kind, less than half of patients prescribed the new class of cholesterol drugs, PCSK9 inhibitors, received insurance approval even if patients had atherosclerotic cardiovascular disease (plaque build-up of the arteries) or markedly elevated bad cholesterol.

Identifying the mechanism for a new class of antiviral drugs could hasten their approval
New research shows that a new class of antiviral drugs works by causing the virus' replication machinery to pause and backtrack, preventing the virus from efficiently replicating.

Read More: Approval News and Approval Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.